Sarcopenia and Systemic Therapy in HCC
NCT06805552 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 270
Last updated 2025-02-03
Summary
This is a multi-center, retrospective observational study in patients with liver cancer (HCC) to assess the impact of sarcopenia (muscle loss) on the prognosis, duration, and tolerance of systemic treatment.
Conditions
- HCC - Hepatocellular Carcinoma
Sponsors & Collaborators
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
collaborator OTHER -
IRCCS Azienda Ospedaliero-Universitaria di Bologna
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-19
- Primary Completion
- 2025-11-01
- Completion
- 2025-11-01
Countries
- Italy
Study Locations
More Related Trials
-
Building of Prognosis Model for Patients With Cirrhosis Based on Sarcopenia Assessed by Deep Learning
NCT06531200 ·Status: NOT_YET_RECRUITING
-
A Cross Sectional Study for Determining Prevalence of Sarcopenia and Myosteatosis in Cirrhotic Patients and to Study the Association Between Imaging and Clinical Parameters
NCT05157308 ·Status: UNKNOWN
-
Impact of Sarcopenia on Postoperative Outcomes of Patients Undergoing Liver Resection
NCT03630978 ·Status: COMPLETED
-
Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension
NCT06245798 ·Status: COMPLETED
-
Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis
NCT03083002 ·Status: UNKNOWN
-
Transient Elastography in Hepatectomy for Hepatocellular Carcinoma
NCT01441453 ·Status: UNKNOWN ·Phase: NA
-
Fibroscan Study in HCC
NCT01796145 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients
NCT06550739 ·Status: COMPLETED
-
HCC Innervation Assessment
NCT06886763 ·Status: ACTIVE_NOT_RECRUITING
-
Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome
NCT03584204 ·Status: RECRUITING
-
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study
NCT00629421 ·Status: COMPLETED
-
Assessment of Frailty in Patients With Advanced Hepatocellular Cancers
NCT02482259 ·Status: COMPLETED
-
Study of Hepatocellular Carcinoma in Cirrhotic Patients
NCT01904942 ·Status: COMPLETED
-
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
NCT04371042 ·Status: RECRUITING
-
Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver Function
NCT03766555 ·Status: UNKNOWN ·Phase: NA
-
MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
NCT05264051 ·Status: RECRUITING
-
Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.
NCT06899854 ·Status: RECRUITING
-
Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients
NCT01798173 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment
NCT01492127 ·Status: UNKNOWN ·Phase: NA
-
Microbiota, Sarcopenia, and Hepatic Encephalopathy Change in Cirrhotic Patients Before and After Rehabilitation
NCT06040814 ·Status: RECRUITING ·Phase: NA
-
GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma
NCT00495846 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Austrian Biobanking Study for Sarcopenia
NCT06632743 ·Status: RECRUITING
-
The Surveillance of Hepatocellular Carcinoma
NCT05286099 ·Status: UNKNOWN
-
Prospective Surveillance for Very Early Hepatocellular Carcinoma
NCT03588442 ·Status: UNKNOWN
-
Liver Cancer HepaSphere Combined With Cryosurgery
NCT02545556 ·Status: COMPLETED ·Phase: PHASE1/PHASE2